Abstract:Different growth factors have been shown to influence the development of form-deprivation myopia and lens-induced ametropias. However, growth factors have relatively little effect on the growth of eyes with unrestricted vision. We investigate whether the combination of insulin-like growth factor 1 (IGF1) and fibroblast growth factor 2 (FGF2) influence ocular growth in eyes with unrestricted vision. Different doses of IGF1 and FGF2 were injected into the vitreous chamber of postnatal chicks. Measurements of ocular dimensions and intraocular pressure (IOP) were made during and at the completion of different treatment paradigms. Histological and immunocytochemical analyses were performed to assess cell death, cellular proliferation and integrity of ocular tissues. Treated eyes had significant increases in equatorial diameter and vitreous chamber depth. With significant variability between individuals, IGF1/FGF2-treatment caused hypertrophy of lens and ciliary epithelia, lens thickness was increased, and anterior chamber depth was decreased. Treated eyes developed myopia, in excess of 15 diopters of refractive error. Shortly after treatment, eyes had increased intraocular pressure (IOP), which was increased in a dose-dependent manner. Seven days after treatment with IGF1 and FGF2 changes to anterior chamber depth, lens thickness and elevated IOP were reduced, whereas increases in the vitreous chamber were persistent. Some damage to ganglion cells was detected in peripheral regions of the retina at 7 days after treatment. We conclude that the extreme myopia in IGF1/FGF2-treated eyes results from increased vitreous chamber depth, decreased anterior chamber depth, and changes in the lens. We propose that factor-induced ocular enlargement and myopia result from changes to the sclera, lens and anterior chamber depth.

Roles of growth factors in eye development and ophthalmic diseases

Growth Factors In The Eye

Progress on the application of growth factor-related drugs in ophthalmology

Growth Factors Regulation in Lens Normal Development

PDGF-C and PDGF-D in Ocular Diseases

The Role of Neurotrophins and Mimetics in the Treatment of Ocular Diseases

[Research Advances of Platelet Derived Growth Factor Family and Its Significance in Neovascular Eye Diseases].

The combination of IGF1 and FGF2 and the induction of excessive ocular growth and extreme myopia

Vascular endothelial growth factor in eye disease

A review of the role of the Wnt signaling pathway in eye development and ophthalmic diseases

Vascular endothelial growth factor and intraocular neovascularization

Role of Glucose Metabolism in Ocular Angiogenesis (Review)

Intraocular neovascularization and cytokine

Involvement of Growth Factors in Diabetes Mellitus and Its Complications: A General Review

The role of cGMP in ocular growth and the development of form-deprivation myopia in guinea pigs

From Insight to Eyesight: Unveiling the Secrets of the Insulin-Like Growth Factor Axis in Retinal Health

Comprehensive Assessment of Growth Factors, Inflammatory Mediators, and Cytokines in Vitreous from Patients with Proliferative Diabetic Retinopathy.

Elevated TGFβ Signaling Inhibits Ocular Vascular Development

The Role of Insulin-like Growth Factor (IGF) System in the Corneal Epithelium Homeostasis—From Limbal Epithelial Stem Cells to Therapeutic Applications

Advances in vascular endothelial growth factor antagonist therapy for ocular neovascularization diseases